Medtronic's US$90.03 share price signals that it might be 33% undervalued ...

Medtronic plc’s MDT growth is backed by remarkable progress within the Neurosurgery Portfolio. The company’s continuous ...

"Medtronic’s PulseSelect system shows lesion durability in Afib treatment" was originally created and published by Medical ...

Discover why Medtronic is a top Dividend Aristocrat with strong financial performance and potential for 12% annual returns ...

Axonics AXNX recently announced that a jury in the U.S. District Court for the Central District of California ruled ...

Medtronic leaned into its robotics and navigation strategy during the third quarter of 2024. Here are four things to know: 1. On the heels of a strong start for Medtronic's fiscal year 2025, CEO Geoff ...

The Medtronic GI Genius™ system demonstrates AI's capacity to improve diagnostic accuracy by serving as a second set of eyes for clinicians, demonstrating 99.7%-100% sensitivity rate when screening ...

Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's ...

A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...

Medtronic plc (MDT) announced that clinical study results demonstrated a high rate of durable lesion formation using the PulseSelect ...

Every investor in Medtronic plc ( NYSE:MDT) should be aware of the most powerful shareholder groups. The group holding the ...

A U.S. Commerce Department official will tour Twin Cities medtech facilities and meet with health care industry leaders this ...